Joe Newell - 15 Nov 2021 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)

Reporting relationship: Chief Operations Officer
Issuer ticker: ATRA
Reported as of: 15 Nov 2021
Net transaction value: -$81,479
SEC form: 4
Accepted by SEC: 17 Nov 2021, 15:15:44 UTC
Prior SEC filing: 24 Sep 2021
Next SEC filing: 18 Nov 2021
Source filing: View source filing
Reporting owner signature: /s/ David Tucker, Attorney-in-Fact for Joe Newell

Key filing fact

Joe Newell filed Form 4 for Atara Biotherapeutics, Inc. (ATRA) on 17 Nov 2021.

Key facts

This page summarizes Joe Newell's Form 4 filing for Atara Biotherapeutics, Inc. (ATRA).
4 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 17 Nov 2021, 15:15.

Change

Previous filing in this sequence was filed on 24 Sep 2021.
Current net transaction value: -$81,479.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ATRA transaction

Common Stock

Options Exercise

Transaction value: $42,525
Shares: +3,500
Change %: +2.9%
Price: $12.15^*
Shares after: 123,429
Date: 15 Nov 2021
Ownership: Direct
Footnotes: F1

ATRA transaction

Common Stock

Sale

Transaction value: $124,004
Shares: -7,000
Change %: -5.7%
Price: $17.71^*
Shares after: 116,429
Date: 15 Nov 2021
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ATRA transaction Derivative

Employee Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -2,792
Change %: -8%
Price: $0.000000
Shares after: 32,083
Date: 15 Nov 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,792
Exercise price: $12.15
Footnotes: F1, F3

ATRA transaction Derivative

Employee Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -708
Change %: -6.7%
Price: $0.000000
Shares after: 9,917
Date: 15 Nov 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 708
Exercise price: $12.15
Footnotes: F1, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Transaction pursuant to Rule 10b5-1 Plan adopted September 14, 2020.

Footnote F2

The price in Column 4 is a weighted average sale price. The prices actually received ranged from $17.62 to $17.85. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Footnote F3

1/48th of the shares subject to the stock option vest and become exercisable each month with the initial installment vesting on April 1, 2020, subject to the reporting person's continuous service.